Back to Search
ROBERTO BISONNI, M.D.
M.D.
Family Medicine Physician
NPI: 1346216686Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
J8916(TX)
Research & Publications (13)
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.
PMID 19259089·Br J Cancer·2009
8-other
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.
PMID 19104506·Pharmacogenomics J·2009
8-other
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.
PMID 17549067·Pharmacogenomics J·2008
4-observational
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.
PMID 18728661·Br J Cancer·2008
8-other
Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer.
PMID 18349392·J Clin Oncol·2008
8-other
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.
PMID 17401013·J Clin Oncol·2007
8-other
Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer.
PMID 17617021·Clin Chem Lab Med·2007
8-other
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
PMID 16988826·Cancer Chemother Pharmacol·2007
3-trial
Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
PMID 16622263·J Clin Oncol·2006
8-other
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.
PMID 16456808·Cancer·2006
3-trial
Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.
PMID 16094648·Int J Cancer·2006
4-observational
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
PMID 15897576·Clin Cancer Res·2005
8-other
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.
PMID 12085175·Br J Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1804 FM 646 RD W, SUITE J
DICKINSON, TX 77539 - Phone
- (281) 534-0400
Quick Facts
- NPI
- 1346216686
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile